nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Mefloquine—BCHE—peripheral nervous system neoplasm	0.0229	0.719	CrCbGaD
Flecainide—Mefloquine—ABCB1—peripheral nervous system neoplasm	0.00897	0.282	CrCbGaD
Flecainide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0088	0.591	CbGbCtD
Flecainide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00377	0.253	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00231	0.155	CbGbCtD
Flecainide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000863	0.000906	CcSEcCtD
Flecainide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.000906	CcSEcCtD
Flecainide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000863	0.000905	CcSEcCtD
Flecainide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000861	0.000903	CcSEcCtD
Flecainide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00086	0.000902	CcSEcCtD
Flecainide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00086	0.000902	CcSEcCtD
Flecainide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000859	0.000901	CcSEcCtD
Flecainide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000859	0.000901	CcSEcCtD
Flecainide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000858	0.0009	CcSEcCtD
Flecainide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000856	0.000898	CcSEcCtD
Flecainide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000856	0.000898	CcSEcCtD
Flecainide—Pain—Vincristine—peripheral nervous system neoplasm	0.000856	0.000898	CcSEcCtD
Flecainide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000856	0.000897	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000856	0.000897	CcSEcCtD
Flecainide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000856	0.000897	CcSEcCtD
Flecainide—Rash—Melphalan—peripheral nervous system neoplasm	0.000853	0.000895	CcSEcCtD
Flecainide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000852	0.000894	CcSEcCtD
Flecainide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000849	0.000891	CcSEcCtD
Flecainide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000846	0.000887	CcSEcCtD
Flecainide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000844	0.000885	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00084	0.000881	CcSEcCtD
Flecainide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000836	0.000877	CcSEcCtD
Flecainide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000827	0.000867	CcSEcCtD
Flecainide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.000866	CcSEcCtD
Flecainide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000861	CcSEcCtD
Flecainide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000861	CcSEcCtD
Flecainide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000821	0.000861	CcSEcCtD
Flecainide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000818	0.000859	CcSEcCtD
Flecainide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000817	0.000858	CcSEcCtD
Flecainide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000814	0.000854	CcSEcCtD
Flecainide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.000854	CcSEcCtD
Flecainide—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000814	0.000853	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000806	0.000846	CcSEcCtD
Flecainide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000844	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000804	0.000843	CcSEcCtD
Flecainide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000804	0.000843	CcSEcCtD
Flecainide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000795	0.000834	CcSEcCtD
Flecainide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000794	0.000833	CcSEcCtD
Flecainide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000791	0.00083	CcSEcCtD
Flecainide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000791	0.00083	CcSEcCtD
Flecainide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000791	0.00083	CcSEcCtD
Flecainide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000789	0.000828	CcSEcCtD
Flecainide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000787	0.000826	CcSEcCtD
Flecainide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000784	0.000822	CcSEcCtD
Flecainide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000778	0.000817	CcSEcCtD
Flecainide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000773	0.000811	CcSEcCtD
Flecainide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000769	0.000807	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000766	0.000804	CcSEcCtD
Flecainide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000764	0.000801	CcSEcCtD
Flecainide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000758	0.000795	CcSEcCtD
Flecainide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000757	0.000794	CcSEcCtD
Flecainide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000747	0.000784	CcSEcCtD
Flecainide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.000782	CcSEcCtD
Flecainide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.000771	CcSEcCtD
Flecainide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000729	0.000765	CcSEcCtD
Flecainide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000729	0.000765	CcSEcCtD
Flecainide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000728	0.000764	CcSEcCtD
Flecainide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000723	0.000758	CcSEcCtD
Flecainide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000756	CcSEcCtD
Flecainide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000721	0.000756	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.000756	CcSEcCtD
Flecainide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000718	0.000753	CcSEcCtD
Flecainide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000717	0.000752	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.000747	CcSEcCtD
Flecainide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.000745	CcSEcCtD
Flecainide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.000741	CcSEcCtD
Flecainide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000705	0.000739	CcSEcCtD
Flecainide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.0007	0.000735	CcSEcCtD
Flecainide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0007	0.000734	CcSEcCtD
Flecainide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0007	0.000734	CcSEcCtD
Flecainide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000699	0.000733	CcSEcCtD
Flecainide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000733	CcSEcCtD
Flecainide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000729	CcSEcCtD
Flecainide—Pain—Etoposide—peripheral nervous system neoplasm	0.000693	0.000727	CcSEcCtD
Flecainide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000693	0.000727	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.000725	CcSEcCtD
Flecainide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.00072	CcSEcCtD
Flecainide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000685	0.000718	CcSEcCtD
Flecainide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000713	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000708	CcSEcCtD
Flecainide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000668	0.000701	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.0007	CcSEcCtD
Flecainide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000665	0.000698	CcSEcCtD
Flecainide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000665	0.000698	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000696	CcSEcCtD
Flecainide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000663	0.000695	CcSEcCtD
Flecainide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000662	0.000694	CcSEcCtD
Flecainide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.000693	CcSEcCtD
Flecainide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000687	CcSEcCtD
Flecainide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.000686	CcSEcCtD
Flecainide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000651	0.000683	CcSEcCtD
Flecainide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000651	0.000683	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.00068	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000678	CcSEcCtD
Flecainide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000644	0.000676	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000674	CcSEcCtD
Flecainide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000641	0.000672	CcSEcCtD
Flecainide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000641	0.000672	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000668	CcSEcCtD
Flecainide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000636	0.000668	CcSEcCtD
Flecainide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000666	CcSEcCtD
Flecainide—Rash—Vincristine—peripheral nervous system neoplasm	0.000631	0.000662	CcSEcCtD
Flecainide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00063	0.000661	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000659	CcSEcCtD
Flecainide—Headache—Vincristine—peripheral nervous system neoplasm	0.000627	0.000658	CcSEcCtD
Flecainide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.000647	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000647	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.000645	CcSEcCtD
Flecainide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000635	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000632	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000627	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000596	0.000626	CcSEcCtD
Flecainide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000594	0.000624	CcSEcCtD
Flecainide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000594	0.000623	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000618	CcSEcCtD
Flecainide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000582	0.00061	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000578	0.000606	CcSEcCtD
Flecainide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000574	0.000602	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000598	CcSEcCtD
Flecainide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000593	CcSEcCtD
Flecainide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000563	0.00059	CcSEcCtD
Flecainide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000585	CcSEcCtD
Flecainide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000585	CcSEcCtD
Flecainide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000555	0.000582	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.00058	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.000579	CcSEcCtD
Flecainide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000576	CcSEcCtD
Flecainide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000576	CcSEcCtD
Flecainide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000573	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000572	CcSEcCtD
Flecainide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000567	CcSEcCtD
Flecainide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000536	0.000562	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.000561	CcSEcCtD
Flecainide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000526	0.000551	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000551	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000549	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000542	CcSEcCtD
Flecainide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000515	0.000541	CcSEcCtD
Flecainide—Rash—Etoposide—peripheral nervous system neoplasm	0.000511	0.000536	CcSEcCtD
Flecainide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000511	0.000536	CcSEcCtD
Flecainide—Headache—Etoposide—peripheral nervous system neoplasm	0.000508	0.000533	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000533	CcSEcCtD
Flecainide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.00053	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000529	CcSEcCtD
Flecainide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000527	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.000525	CcSEcCtD
Flecainide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000525	CcSEcCtD
Flecainide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000524	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000523	CcSEcCtD
Flecainide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000516	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000513	CcSEcCtD
Flecainide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000486	0.00051	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000509	CcSEcCtD
Flecainide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000506	CcSEcCtD
Flecainide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000482	0.000505	CcSEcCtD
Flecainide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000504	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000501	CcSEcCtD
Flecainide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000497	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000497	CcSEcCtD
Flecainide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000497	CcSEcCtD
Flecainide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000496	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000494	CcSEcCtD
Flecainide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000491	CcSEcCtD
Flecainide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000487	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000486	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000486	CcSEcCtD
Flecainide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000485	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000484	CcSEcCtD
Flecainide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000481	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000478	CcSEcCtD
Flecainide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000477	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000475	CcSEcCtD
Flecainide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000472	CcSEcCtD
Flecainide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000469	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000468	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000468	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000467	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000467	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000465	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000463	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000461	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.00046	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.00046	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.00046	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000459	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000457	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000455	CcSEcCtD
Flecainide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000454	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.00045	CcSEcCtD
Flecainide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000445	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000445	CcSEcCtD
Flecainide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000441	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000434	CcSEcCtD
Flecainide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000434	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000433	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000432	CcSEcCtD
Flecainide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000431	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000431	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000428	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000428	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000426	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000425	CcSEcCtD
Flecainide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000424	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.00042	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00042	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000414	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000412	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000412	CcSEcCtD
Flecainide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000411	CcSEcCtD
Flecainide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000408	CcSEcCtD
Flecainide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000408	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000402	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000399	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000396	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000393	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000393	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000392	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000372	0.00039	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000388	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000383	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000381	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.00038	CcSEcCtD
Flecainide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000379	CcSEcCtD
Flecainide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000377	CcSEcCtD
Flecainide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000377	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000377	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000377	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000363	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000361	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00035	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000349	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000349	CcSEcCtD
Flecainide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000342	CcSEcCtD
Flecainide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000337	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000326	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000316	CcSEcCtD
Flecainide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000315	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000312	CcSEcCtD
Flecainide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000303	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000302	CcSEcCtD
Flecainide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000301	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.0003	CcSEcCtD
Flecainide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000299	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000292	CcSEcCtD
Flecainide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000283	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00028	CcSEcCtD
Flecainide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000278	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000278	CcSEcCtD
Flecainide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000276	CcSEcCtD
Flecainide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000262	CcSEcCtD
